fluoxymesterone has been researched along with epitiostanol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsuzawa, A; Yamamoto, T | 1 |
Hashizume, Y; Hirano, M; Ishida, K; Iwa, T; Katada, S; Kawaura, Y; Yamada, T | 1 |
Miura, S; Yoshida, M | 1 |
1 trial(s) available for fluoxymesterone and epitiostanol
Article | Year |
---|---|
[Internal endocrine therapy of breast cancer].
Topics: Androstanols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diethylstilbestrol; Double-Blind Method; Female; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Testosterone | 1984 |
2 other study(ies) available for fluoxymesterone and epitiostanol
Article | Year |
---|---|
Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4).
Topics: Androstanes; Androstanols; Animals; Antineoplastic Agents; Body Weight; Castration; Female; Fluoxymesterone; Male; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Organ Size; Ovary; Pituitary Gland; Pregnancy; Pregnancy, Animal; Sulfides; Transplantation, Isogeneic | 1977 |
[Treatment of chemo-endocrine therapy in recurrent breast cancer].
Topics: Adult; Androstanols; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Fluoxymesterone; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Tamoxifen | 1986 |